ECM

ECM
Name	Extracellular matrix
Field	Cell biology, Developmental biology, Histology
Introduced	19th century

ECM

The extracellular matrix is a complex network of macromolecules that provides structural support and biochemical signaling in multicellular organisms. It interacts with cells, tissues, and organs to influence Embryogenesis, Wound healing, Cancer progression, and Tissue engineering. Studies span multiple disciplines including Molecular biology, Biochemistry, Pathology, and Regenerative medicine.

Definition and Scope

The extracellular matrix comprises proteins, glycoproteins, and polysaccharides secreted by cells to form an organized scaffold that regulates cell behavior in Vertebrata, Invertebrata, and plant lineages such as Angiosperms. Components include fibrillar molecules produced by Fibroblasts, adhesive proteins synthesized by Epithelial cells, and proteoglycans secreted by Chondrocytes. ECM functions are central to processes described in works by researchers affiliated with institutions like Max Planck Society, National Institutes of Health, Salk Institute, and Howard Hughes Medical Institute.

History and Development

Early descriptions of connective tissues appeared in texts by anatomists such as Galen and later by Marcello Malpighi; microscopic characterization advanced with the inventions of Hooke and Leeuwenhoek. Nineteenth- and twentieth-century contributions from researchers at University of Cambridge, Johns Hopkins University, and University of Paris clarified roles for collagen and elastin following discoveries by Rudolf Virchow and Alfred Nobel-era chemists. Landmark biochemical elucidations were driven by laboratories including those of Linus Pauling, Robert L. Sinsheimer, and groups at Massachusetts Institute of Technology that developed methods still used in Electron microscopy and X-ray crystallography.

Types and Variants

Major ECM types include interstitial matrix abundant in connective tissues studied in Skin, Lung, and Liver research, and basement membrane specialized under epithelia investigated in studies of Kidney glomeruli and Placenta. Variants such as perineuronal nets appear in investigations at institutions like Cold Spring Harbor Laboratory and clinical contexts involving Alzheimer's disease. Structural molecules include families exemplified by Collagen type I, Elastin, laminins characterized in reports from University College London, and proteoglycans such as aggrecan highlighted in Osteoarthritis research. Specialized matrices in Cartilage, Bone, and Tooth each feature distinct molecular signatures documented in journals associated with Nature Publishing Group and Cell Press.

Applications and Uses

Extracellular matrix knowledge underpins therapeutic approaches in Regenerative medicine, Orthopedics, and Dermatology. Decellularized ECM scaffolds developed by groups at Wake Forest Institute for Regenerative Medicine and ETH Zurich are employed in clinical trials overseen by regulators like Food and Drug Administration and European Medicines Agency. Biomaterials inspired by ECM inform designs used by companies such as Medtronic and startups incubated at Massachusetts Institute of Technology. Analytical applications include biomarkers for Cancer prognosis utilized in clinical centers like Mayo Clinic and imaging contrast agents studied at Stanford University.

Mechanisms and Composition

ECM assembly is mediated by secretion pathways elucidated by researchers at EMBL and involves enzymatic crosslinking by proteins such as lysyl oxidase researched at Harvard Medical School. Cell–matrix communication occurs via transmembrane receptors like integrins first characterized in studies from University of California, San Diego and signaling cascades involving focal adhesion kinases investigated at University of Pennsylvania. Matrix remodeling is driven by matrix metalloproteinases extensively studied in laboratories at University of Oxford and regulated by inhibitors such as TIMPs described in collaborations with Imperial College London.

Research and Controversies

Current research debates address roles of ECM stiffness in Metastasis, interpretations by teams at University of Cambridge versus models from Broad Institute, and reproducibility concerns raised in meta-analyses involving consortia like International Cancer Genome Consortium. Controversies include ethical and regulatory issues for xenogeneic ECM products discussed in forums at World Health Organization and patent disputes adjudicated at courts such as the European Court of Human Rights and national patent offices. Emerging fields integrate ECM studies with Single-cell sequencing and computational platforms developed by groups at Carnegie Mellon University and ETH Zurich.

Category:Cell biology